An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion

IQVIA Holdings Inc. CEO Ari Bousbib sold approximately 106,000 shares for $26.1 million by exercising expiring stock appreciation rights. This transaction is considered calendar management rather than a reflection of his outlook on the company, as he retained a significant beneficial ownership of 1.4 million shares. The sale followed a strong quarter for IQVIA, which reported record clinical bookings of $3.15 billion and raised its full-year guidance.